Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Ridgemont Equity Partners will acquire the trucking brokerage firm Worldwide Express and combine it with its own trucking unit to create one of the largest third-party logistics providers in the U.S., according to The Wall Street Journal.
Kaleo will provide its Auvi-Q emergency epinephrine auto-injector to many patients at no cost, although the device's list price — which payers will negotiate discounts and rebates from — will be set at $4,500, reports Reuters.
While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the Department of Justice, reports Reuters.
After President Donald Trump said drugmakers were "getting away with murder" during his Jan. 11 press conference, leaders of the pharmaceutical industry responded with varying views.
Researchers at the Feinstein Institute for Medical Research in Manhasset, N.Y., are learning a new language to communicate with the body and redefine treatment of disease and injury — the language of bioelectronic medicine.
After withholding financial support from President-elect Donald Trump during last summer's Republican National Convention, United Parcel Service — along with several other major corporations — contributed to Mr. Trump's inaugural committee, reports The Wall Street Journal.
Mallinckrodt will pay $100 million to settle Federal Trade Commission claims that its U.S. subsidiary, Questcor, illegally raised the price of its autoimmune drug by 85,000 percent and purchased the rights to a cheaper version of the drug to keep…
Researchers discovered how drug spending is allocated across the pharmaceutical supply chain in a new study from Berkeley Research Group.
Here are six articles published by Becker's Hospital Review in the past week that highlight device issues or recalls, blood shortages and the fight against high drug prices, among other issues.
"Hospitals and health systems are experiencing an unprecedented escalation in the cost of older, commonplace drugs with new price increases," says Tom Fox, a managing director at healthcare consulting firm Novia Strategies.